Skip to main content
Figure 2 | Breast Cancer Research

Figure 2

From: p66 Shc and tyrosine-phosphorylated Shc in primary breast tumors identify patients likely to relapse despite tamoxifen therapy

Figure 2

Relapse-free survival (RFS) according to Shc in patients with breast cancer. (a) Kaplan-Meier graphical analysis of RFS in patients from the population-based cohort partitioned by the median value for Shc (P = 0.013). (b) Kaplan-Meier graphical analysis of RFS in patients from the case-control cohort partitioned by the median value for Shc (P = 0.035).

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us